Ziqiang Tian

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial

Yong Li, Aiping Zhou, Shuoyan Liu et al. · BMC Medicine · 2023 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of the key transcription factors in esophageal squamous cell carcinoma

Yuefeng Zhang, Yanzhao Xu, Zhenhua Li et al. · Journal of Thoracic Disease · 2018 · 41 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17

Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China

Yang Yang, Lijie Tan, Jian Hu et al. · Diseases of the Esophagus · 2022 · 39 citations

Medicine, Immunology, Oncology +17

Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching

Shaowu Jing, Chang Zhai, Wei Zhang et al. · Frontiers in Immunology · 2022 · 39 citations · Full text

Medicine, Oncology, Surgery +15

Soluble c-Met Is a Reliable and Sensitive Marker to Detect c-Met Expression Level in Lung Cancer

Huilai Lv, Baoen Shan, Ziqiang Tian et al. · BioMed Research International · 2015 · 30 citations · Full text

Medicine, Cancer Biology, Oncology +13